Aurinia Pharmaceuticals Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-70.8M | $-23.3M |
| Depreciation & Amortization | — | — |
| Depreciation | $22.0K | $22.0K |
| Amortization | $1.4M | $1.5M |
| Stock-Based Compensation | $4.2M | — |
| Net Cash from Operating Activities | $-41.2M | $-18.7M |
| Investing Activities | ||
| Capital Expenditures | $25.0K | $15.0K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-8.0M | $10.0M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $175.2M | $42.6M |
| Net Change in Cash | $126.0M | $33.9M |
| Free Cash Flow | $-41.2M | $-18.7M |